Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Rivaroxaban
Other

Rivaroxaban

Tracked across 1 events · 6 articles · First seen Jun 01, 2026 · Last active Jun 01, 2026

Sentiment
50
Attention
3
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
3 50
Business
Sunshine Biopharma's Rivaroxaban Approved in Canada
Impact: Rivaroxaban is the generic anticoagulant drug that received approval in Canada, representing a significant market opportunity for Sunshine Biopharma.
Jun 01, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Rivaroxaban live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.